| Typicality: | 0.397 |
| Saliency: | 0.344 |
| from orlistat | 20 | location |
| aside | 6 | manner |
| reason → be authorized by → the fda | 14 |
| reason → be licensed by → the fda | 10 |
| reason → be approved by → the fda | 9 |
| negative | neutral | positive |
| 0.194 | 0.594 | 0.213 |
| Raw frequency | 33 |
| Normalized frequency | 0.344 |
| Modifier score | 0.500 |
| Perplexity | 127.329 |